Ching Lum is an experienced medical affairs professional with 20 years in the industry, focusing on rare disease medical strategy development. Currently serving as the Director of Medical Affairs at Regeneron since 2022, Ching has previously held significant roles at Novo Nordisk and Alexion Pharmaceuticals. Ching's therapeutic expertise includes hematology, nephrology, and complement immunology, demonstrating a robust engagement with both internal and external stakeholders. Ching earned a PharmD in Pharmacy from the University at Buffalo in 2000.
This person is not in the org chart
This person is not in any teams
This person is not in any offices